FDA clears personalized brain stimulation treatment for post traumatic stress disorder

A new treatment for post-traumatic stress disorder that uses personalized brain mapping and magnetic stimulation has received approval from the United States Food and Drug Administration, ScienceDaily reported. The therapy was developed by California-based Wave Neuroscience alongside researchers at the Texas A and M Health Institute of Biosciences and Tech. [1]

ScienceDaily reported that a clinical trial of the technology showed a 52 percent reduction in symptoms and a 68 percent remission rate. The treatment targets abnormal brain activity to provide a personalized alternative for individuals who have not found relief through existing options. [1]

Post-traumatic stress disorder can develop after a person experiences a traumatic event such as warfare, domestic violence, or traffic collisions. Symptoms include disturbing thoughts, mental or physical distress to trauma-related cues, and alterations in how a person thinks and feels, which last for more than a month after the event. [2]

Researchers believe that this newly cleared technology could transform care for post-traumatic stress disorder, ScienceDaily reported. They also anticipate that the approach will lead the way to more precise treatments for other mental health conditions in the future. [1]